199 related articles for article (PubMed ID: 36882365)
41. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.
Landreneau RJ; Normolle DP; Christie NA; Awais O; Wizorek JJ; Abbas G; Pennathur A; Shende M; Weksler B; Luketich JD; Schuchert MJ
J Clin Oncol; 2014 Aug; 32(23):2449-55. PubMed ID: 24982447
[TBL] [Abstract][Full Text] [Related]
42. Oncologic outcomes of lobectomy
Zheng YZ; Zhai WY; Zhao J; Luo RX; Gu WJ; Fu SS; Wu D; Yuan LX; Jiang W; Tsutani Y; Liao HY; Li XQ
J Thorac Dis; 2020 Jun; 12(6):3178-3187. PubMed ID: 32642239
[TBL] [Abstract][Full Text] [Related]
43. Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer.
Handa Y; Tsutani Y; Mimae T; Miyata Y; Ito H; Shimada Y; Nakayama H; Ikeda N; Okada M
Ann Thorac Surg; 2022 Apr; 113(4):1317-1324. PubMed ID: 34022215
[TBL] [Abstract][Full Text] [Related]
44. A Multi-Institutional, Randomized, Phase III Trial Comparing Anatomical Segmentectomy and Lobectomy for Clinical Stage IA3 Pure-Solid Non-Small-Cell Lung Cancer: West Japan Oncology Group Study WJOG16923L (STEP UP Trial).
Kamigaichi A; Hamada A; Tsuboi M; Yoshimura K; Okamoto I; Yamamoto N; Tsutani Y
Clin Lung Cancer; 2024 Jun; 25(4):384-388.e1. PubMed ID: 38360496
[TBL] [Abstract][Full Text] [Related]
45. Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer.
Zhang Y; Sun Y; Wang R; Ye T; Zhang Y; Chen H
J Surg Oncol; 2015 Mar; 111(3):334-40. PubMed ID: 25322915
[TBL] [Abstract][Full Text] [Related]
46. Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer.
Chan EG; Chan PG; Mazur SN; Normolle DP; Luketich JD; Landreneau RJ; Schuchert MJ
J Thorac Cardiovasc Surg; 2021 May; 161(5):1639-1648.e2. PubMed ID: 32331817
[TBL] [Abstract][Full Text] [Related]
47. Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.
Tsutani Y; Kagimoto A; Handa Y; Mimae T; Miyata Y; Okada M
Jpn J Clin Oncol; 2019 Dec; 49(12):1134-1142. PubMed ID: 31602468
[TBL] [Abstract][Full Text] [Related]
48. Ground glass opacity resection extent assessment trial
Li H; Wang Y; Chen Y; Zhong C; Fang W
Front Oncol; 2023; 13():1052796. PubMed ID: 36741022
[TBL] [Abstract][Full Text] [Related]
49. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study.
Liu Y; Huang C; Liu H; Chen Y; Li S
World J Surg Oncol; 2014 May; 12():138. PubMed ID: 24886396
[TBL] [Abstract][Full Text] [Related]
50. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
[TBL] [Abstract][Full Text] [Related]
51. Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer.
Kamigaichi A; Mimae T; Tsubokawa N; Miyata Y; Adachi H; Shimada Y; Ito H; Ikeda N; Okada M
Interdiscip Cardiovasc Thorac Surg; 2023 Sep; 37(3):. PubMed ID: 37589650
[TBL] [Abstract][Full Text] [Related]
52. Long-term outcomes of open and video-assisted thoracoscopic lung lobectomy for the treatment of early stage non-small cell lung cancer are similar: a propensity-matched study.
Murakawa T; Ichinose J; Hino H; Kitano K; Konoeda C; Nakajima J
World J Surg; 2015 May; 39(5):1084-91. PubMed ID: 25561187
[TBL] [Abstract][Full Text] [Related]
53. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy for small-sized stage IA lung cancer.
Zhong C; Fang W; Mao T; Yao F; Chen W; Hu D
Ann Thorac Surg; 2012 Aug; 94(2):362-7. PubMed ID: 22727321
[TBL] [Abstract][Full Text] [Related]
54. Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller.
Zhang C; He Z; Cheng J; Cao J; Hu J
Clin Lung Cancer; 2021 Mar; 22(2):e160-e168. PubMed ID: 33160898
[TBL] [Abstract][Full Text] [Related]
55. Lymph node dissections and survival in sublobar resection of non-small cell lung cancer ≤ 20 mm.
Takamori S; Komiya T; Shimokawa M; Powell E
Gen Thorac Cardiovasc Surg; 2023 Mar; 71(3):189-197. PubMed ID: 36178575
[TBL] [Abstract][Full Text] [Related]
56. The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer.
Raman V; Jawitz OK; Voigt SL; Rhodin KE; D'Amico TA; Harpole DH; Jeffrey Yang CF; Tong BC
Chest; 2021 Jan; 159(1):390-400. PubMed ID: 32652096
[TBL] [Abstract][Full Text] [Related]
57. Oncologic outcomes of segmentectomy versus lobectomy for clinical T1c radiological pure-solid non-small-cell lung cancer.
Hattori A; Takamochi K; Matsunaga T; Fukui M; Suzuki K
Interdiscip Cardiovasc Thorac Surg; 2023 Nov; 37(5):. PubMed ID: 37738593
[TBL] [Abstract][Full Text] [Related]
58. Less is more in solid-dominant lung cancer? Sublobar resection versus lobectomy for solid-dominant stage IA non-small-cell lung cancer: A meta-analysis study.
Guo J; Liu Y; Tian X; Ren Z; Lin J; Wang B; Liang C
Mol Clin Oncol; 2019 Nov; 11(5):465-473. PubMed ID: 31620277
[TBL] [Abstract][Full Text] [Related]
59. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
[TBL] [Abstract][Full Text] [Related]
60. Comparative analysis of the long-term outcomes of segmentectomy and lobectomy for stage IA1 lung adenocarcinoma in patients with or without previous malignancy of other organs: a population-based study.
Bai W; Zhang J; Wang Y; Zhou M; Liu L; Wang G; Zhao K; Gao X; Li S
Expert Rev Anticancer Ther; 2022 Feb; 22(2):215-228. PubMed ID: 34596477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
